It is typically caused by a germline pathogenic variant (PV) in TP53, a well-known tumor suppressor gene, and has a reported prevalence ranging from 1 to 3,555 in patients with a family history of LFS associated cancers to 1 in 5,476 in population based genomic studies [3, 4]. This evidence concerns the gene TP53 and cancer.